Mark Dannatt

Mark Dannatt is a skilled leader in commercial portfolio management, currently serving as the Vice President at Pfizer since 2021. With a background that includes roles such as Portfolio Optimization Leader and Vice President of Business Operations & Transformation, they have consistently driven significant improvements in operational effectiveness and financial performance. Mark's previous experience includes key positions at United Biscuits and GlaxoSmithKline, where they excelled in operations management and change initiatives. They hold a 2.1 BSc (Hons) in Management Sciences from the University of Warwick, which lays the foundation for their expertise in management consulting and Lean Six Sigma methodologies.